OPS: seminario virtual en investigación ética para COVID-19 – hoy, 30 de marzo, de 2 a 3:30pm (hora de Washington, DC)
Lo invitamos a participar en este seminario virtual donde se presentará y discutirá la orientación ética para la investigación sobre COVID-19 de la OPS disponible en: https://www.paho.org/es/documentos/orientacion-etica-sobre-cuestiones-planteadas-por-pandemia-nuevo-coronavirus-covid-19.
Hoy, 30 de marzo, de 2 a 3:30pm (hora de Washington, DC)
Para participar diríjase a: https://paho.webex.com/paho/onstage/g.php?MTID=e9bcc2a227ad498f78625158a65422143
Aguardamos a todos.
Saludos cordiales,
Secretariado Red PARF
Expedited access to disinfectants, hand sanitizers and personal protective equipment to help limit the spread of COVID-19, as well as swabs for testing
Expedited access to disinfectants, hand sanitizers and personal protective equipment to help limit the spread of COVID-19, as well as swabs for testing
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72623a-eng.php
Certain Lots of Taro-Zoledronic acid injection drug, used for osteoporosis and Paget’s disease, recalled due to potential presence of particulate matter
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72673a-eng.php
Methadone Treatment of Opioid Dependence and Potential Differences in Product Effect
Methadone Treatment of Opioid Dependence and Potential Differences in Product Effect
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72675a-eng.php
Cuatro personas recuperadas luego enfrentar COVID-19
Cuatro personas recuperadas luego enfrentar COVID-19
30 de marzo 2020. El Ministro de Salud, Daniel Salas informó que ya se registran cuatro personas recuperadas luego haber enfrentado la enfermedad COVID-19.
Registre d’inscription pour la lutte contre le COVID-19
Registre d’inscription pour la lutte contre le COVID-19
Bulletin du 29 Mars 2020 de la surveillance du nouveau Coronavirus 2019(COVID-19)
Bulletin du 29 Mars 2020 de la surveillance du nouveau Coronavirus 2019(COVID-19)
Coronavirus (COVID-19) Update: FDA expedites review of diagnostic tests to combat COVID-19
Coronavirus (COVID-19) Update: FDA expedites review of diagnostic tests to combat COVID-19
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expedites-review-diagnostic-tests-combat-covid-19
FDA on Signing of the COVID-19 Emergency Relief Bill, Including Landmark Over-the-Counter Drug Reform and User Fee Legislation
FDA on Signing of the COVID-19 Emergency Relief Bill, Including Landmark Over-the-Counter Drug Reform and User Fee Legislation
http://www.fda.gov/news-events/press-announcements/fda-signing-covid-19-emergency-relief-bill-including-landmark-over-counter-drug-reform-and-user-fee
